Estradiol

Especificaciones

50-28-2Número CAS

200-023-8Número CE

(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diolNombre IUPAC

C18H24O2Fórmula química

272.4 g/molPeso molecular

estradiol; beta-Estradiol; 50-28-2; 17beta-Estradiol; Oestradiol; Dihydrofolliculin; Estrace; Aquadiol; Diogynets; Divigel; Vivelle; Diogyn; Dihydrotheelin; Dihydroxyestrin; Dimenformon; Estraderm; Femestral; Gynoestryl; Aerodiol; Climara; Gynergon; Vagifem; Estraldine; Estrogel; Evorel; Estring; Systen; Zumenon; estradiol-17beta; cis-Estradiol; Compudose; Innofem; Alora; Fempatch; Gynodiol; Ovocylin; Esclim; 17beta-Oestradiol; Elestrin; Evamist; 17-beta-estradiol; Menostar; 3,17-Epidihydroxyestratriene; Estraderm TTS 50; Estraderm MX; VIVELLE-DOT; Estra-1,3,5(10)-triene-3,17beta-diol; NSC-9895; Oestradiol-17beta; (17beta)-Estra-1,3,5(10)-triene-3,17-diol; 17 beta-Estradiol; 17beta oestradiol; Estradiol-17 beta; Elestrim; Minivelle; Estradiol Anhydrous; Estradiol 17-beta; 17-beta-oestradiol; (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; Estraderm TTS 100; NSC-20293; DTXSID0020573; IMVEXXY; Estradiol valerate metabolite e2; CHEBI:16469; Estra-1,3,5(10)-triene-3,17-diol (17beta)-; S21400 (INTRANASAL); 4TI98Z838E; 3,17beta-Dihydroxyestra-1,3,5(10)-triene; 17beta-Estra-1,3,5(10)-triene-3,17-diol; WC3011; WC-3011; s21400; DTXCID80573; CHEBI:23965; NSC9895; ORIAHNN COMPONENT ESTRADIOL; S 21400; Aquagen; Gvnodiol; Gynogen; Sandrena; Yuvafem; Bedol; NSC20293; Adgyn estro; Elleste solo; Progynova ts; Estradiol Gel; Estradiol pellet; Estradiol,; E-Cypionate; Vivelle Dot; Estradiol Vaginal; Estrogen 4X; Dermestril 25; Dermestril 50; Estradiol 17beta; Vagifem 8; Estraderm mx 25; Estraderm mx 50; Estraderm mx 75; Fematrix 40; Fematrix 80; Femseven 50; Femseven 75; Menorest 50; Menorest 75; Menoring 50; Dermestril 100; Estraderm tts 25; estradiol valeriante; (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol; Vagifem 18; 17 beta Estradiol; Estradiol 17 beta; Femseven 100; 17 beta Oestradiol; 17 beta-Oestradiol; Estraderm mx 100; Estradiol 1557; Estradiol 17 alpha; Estradiol Transdermal; Evorel 25; Evorel 50; Evorel 75; Therapeutic Estradiol; DOTTI; LYLLANA; Menorest 37.5; Elleste solo mx 40; Elleste solo mx 80; Estra-25; Estra-50; Dermestril septem 25; Dermestril septem 50; Dermestril septem 75; Evorel 100; Estradiol Gel 0.1%; Estradiol Vaginal Cream; RefChem:6428; ESTROGEN PHENOLIC; Estradiol, (17-alpha)-; Estradiol Transdermal System; ESTRADIOL VAGINAL INSERTS; (1S,10R,11S,14S,15S)-15-methyltetracyclo(8.7.0.02,7.011,15)heptadeca-2(7),3,5-triene-5,14-diol; 200-023-8; Benzhormovarine; progynon; Ovocyclin; Follicyclin; Bardiol; Corpagen; Estrovite; Ginosedol; Lamdiol; Macrodiol; Oestergon; Ovahormon; Ovasterol; Ovastevol; Perlatanol; Primofol; Profoliol; Syndiol; Altrad; Dihydromenformon; Oestroglandol; Nordicol; Estroclim; Trocosone; Menorest; D-Oestradiol; D-Estradiol; Estraderm TTS; Progynon DH; Progynon-DH; Climaderm; Dermestril; Ovocycline; Encore; Oesclim; Dihydroxyoestrin; SK-Estrogens; Gynestrel; Microdiol; Oestrogynal; Ovociclina; Tradelia; Estroclim 50; Macrol; Zerella; Oestradiol R; Estring vaginal ring; Trial SAT; Theelin, dihydro-; Oestrogel; Compudose 200; Compudose 365; Profoliol B; Estradiol-17-beta; Estradot; Gelestra; Zesteem; Dihydroxyesterin; cis-Oestradiol; 17.beta.-Estradiol; B-Estradiol; Epiestriol 50; Femanest; 3,17-Epidihydroxyoestratriene; 17b-Oestradiol; Sandrena 1; Estraderm (TN); [3H]-estradiol; 17|A-Oestradiol; Estrogel (TN); Climara (TN); Divigel (TN); Estrace (TN); Estring (TN); Innofem (TN); Vagifem (TN); Vivelle (TN); Estradiol (Standard); 17.beta.-Oestradiol; 3,17.beta.-Estradiol; .beta.-Estradiol; .beta.-Oestradiol; [3H]]estradiol; (17beta)-estra-1(10),2,4-triene-3,17-diol; Estradiol, .beta.-; Estradiol-17.beta.; Oestradiol-17.beta.; 17-.beta.-oestradiol; Oestra-1,3,5(10)-triene-3,17beta-diol; 17|A-estradiol; Estrasorb (TN); 17.beta.-OH-estradiol; 17.beta.-OH-oestradiol; 17beta estradiol (E2); Extrasorb; Estreva; Estrifam; Femtran; Ginedisc; MFCD00003693; CHEMBL135; GynPolar; Sandrena Gel; D-3,17.beta.-Estradiol; D-3,17.beta.-Oestradiol; Sisare Gel; Estra-1,3,5(10)-triene-3,17-diol, (17beta)-; Estrofem 2; MLS000069494; (+)-3,17.beta.-Estradiol; Oestradiolum; Climara Forte; Oestradiol Berco; [3H]E2; 17 ?-Estradiol; Estrapak 50; (8R,9S,13S,14S,17S)-13-Methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; Estradiolum [INN]; Estradiolo [DCIT]; NCGC00091544-04; Oestradiol-17-beta; Estradiolum; Estrodiolum; Estradiolo; Femestrol; SMR000059126; Estradiol-3,17beta; 3,17b-Dihydroxyestra-1,3,5(10)-triene; 17-beta-OH-estradiol; 3,17-beta-Estradiol; 3,17-beta-Oestradiol; D-3,17beta-Estradiol; 3,17.beta.-Dihydroxyestra-1,3,5(10)-triene; E(sub 2); Methyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate.; Benzogynestry; Estropause; Estasorb; [2,4,6,7-3H]-E2; 17916-67-5; E 2; Estra-1,3,5(10)-triene-3,17-diol (17beta)-, (+/-)-; Yuvvexy; Zesteen; .alpha.-Estradiol; 17-beta-OH-oestradiol; D-3,17beta-Oestradiol; D-3,17-beta-Estradiol; Estrodiolum [INN-Latin]; Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-; D-3,17-beta-Oestradiol; Activella (Salt/Mix); Combipatch (Salt/Mix); (1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-triene-5,14-diol; E2; CCRIS 280; component of Menrium; Climara Pro (Salt/Mix); 3,17beta-Estradiol; 3,17-.beta.-Oestradiol; HSDB 3589; 3,3,5(10)-triene; rec IFN-gamma (human); SR-01000075866; 17-.BETA.-Estradiol; EINECS 200-023-8; 1,3,5-Estratriene-3,17-beta-diol; oestrodiol; Estradiol [USP:INN:BAN]; 3,17beta-Dihydroxyestra-1,3,5-triene; 3,17beta-Dihydroxyoestra-1,3,5-triene; delta-Estradiol; dihydro-Theelin; dl-estradiol; 3,17-beta-Dihydroxyoestra-1,3,5-triene; UNII-4TI98Z838E; delta-Oestradiol; TX-004HR; 1,3,5-Estratriene-3,17beta-diol; Estra-1,3,5(10)-triene-3,17-beta-diol; Estrogel HBF; Oestra-1,3,5(10)-triene-3,17-beta-diol; 1jgl; 1lhu; 1qkt; 1qku; 3,17-beta-Dihydroxyestra-1,3,5(10)-triene; ST 18:3;O2; [3H]estradiol; 1,3,5-Estratriene-3,17.beta.-diol; 3,17-beta-Dihydroxy-1,3,5(10)-oestratriene; CAS-50-28-2; 17-beta-Estra-1,3,5(10)-triene-3,17-diol; 17beta-Oestra-1,3,5(10)-triene-3,17-diol; .alpha.-Oestradiol; 17-beta-Oestra-1,3,5(10)-triene-3,17-diol; Prestwick_207; 3,17b-Estradiol; Bio-E-Gel; Fem7; [3H]-Estrogen; 3,17.beta.-Dihydroxyestra-1,3,5-triene; 3,17.beta.-Dihydroxyoestra-1,3,5-triene; CMC_11154; Estradiol-17 alpha; 1,3,5,(10)-Estratrien-3,17.beta.-diol; SL-1100; 17 .beta.-estradiol; Beta-estradiol (E2); Estra-1,3,5(10)-triene-3,17.beta.-diol; Oestra-1,3,5(10)-triene-3,17.beta.-diol; 2j7x; 3,17.beta.-Dihydroxy-1,3,5(10)-estratriene; 3,17.beta.-Dihydroxy-1,3,5(10)-oestratriene; 3,3,5-triene; [3H]17beta-estradiol; ESTRADIOL [INN]; ESTRADIOL [JAN]; 17.beta.-Estra-1,3,5(10)-triene-3,17-diol; ESTRADIOL [MI]; |?-Estradiol(Standard); ESTRADIOL [HSDB]; 17.beta.-Oestra-1,3,5(10)-triene-3,17-diol; Opera_ID_1688; Prestwick0_000441; Prestwick1_000441; Prestwick2_000441; Prestwick3_000441; Spectrum5_002055; 17beta-estradiol (E2); ESTRADIOL [VANDF]; alpha-estradiol (obsolete); beta-Estradiol, >=98%; bmse000642; Epitope ID:136018; Epitope ID:140085; (+)-3,17b-Estradiol; E 8875; EC 200-023-8; ESTRADIOL [USP-RS]; ESTRADIOL [WHO-DD]; SCHEMBL8049; (+)-3,17beta-Estradiol; Estradiol (JAN/USP/INN); Tritiated estradiol-17-beta; BIDD:PXR0065; Lopac0_000503; S-21400; BSPBio_000482; BSPBio_001065; KBioGR_000405; KBioGR_002269; KBioSS_000405; KBioSS_002270; MLS000758312; MLS001076331; MLS001424022; BIDD:ER0125; SPBio_002421; ESTRADIOL [GREEN BOOK]; BPBio1_000532; GTPL1012; GTPL1013; orb1309940; orb3139628; SCHEMBL7525926; ESTRADIOL [ORANGE BOOK]; NIOSH/KG7030000; SCHEMBL11037492; SCHEMBL29350151; BDBM17292; BIJUVA COMPONENT ESTRADIOL; HY-B0141R; KBio2_000405; KBio2_002269; KBio2_002973; KBio2_004837; KBio2_005541; KBio2_007405; KBio3_000769; KBio3_000770; KBio3_002749; ESTRADIOL [USP MONOGRAPH]; MSK2212; 1a52; 1g50; 2d06; ANGELIQ COMPONENT ESTRADIOL; cMAP_000005; ESTRADIOL IMPURITY A [IP]; PREFEST COMPONENT ESTRADIOL; Bio1_000403; Bio1_000892; Bio1_001381; Bio2_000363; Bio2_000843; CS336; GLXC-06851; HMS1362E07; HMS1569I04; HMS1792E07; HMS1990E07; HMS2051C17; HMS2090E18; HMS2096I04; HMS2236H04; HMS3261F07; HMS3403E07; HMS3713I04; HMS3884A08; 1,3,5-Estratriene-3,17b-diol; beta-Estradiol, analytical standard; (8S,9S,13S,14S,17S)-13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; ACTIVELLA COMPONENT ESTRADIOL; ESTRADIOL 17-BETA [VANDF]; HY-B0141; Tox21_111148; Tox21_202057; Tox21_300288; Tox21_500503; 1,5-Estratriene-3,17.beta.-diol; COMBIPATCH COMPONENT ESTRADIOL; EBC-06093; HB2494; LMST02010001; MSK2212-100A; s1709; Estradiol for peak identification CRS; Estradiol-17-beta-6,7-(sup 3)H; [2,4,6,7-3H]-17beta-estradiol; AKOS015896570; CLIMARA PRO COMPONENT ESTRADIOL; MSK2212-1000A; CCG-100808; CS-1938; DB00783; FE10880; LP00503; NC00058; SDCCGSBI-0050487.P002; IDI1_002118; SMP1_000121; NCGC00091544-00; NCGC00091544-01; NCGC00091544-02; NCGC00091544-05; NCGC00091544-06; NCGC00091544-07; NCGC00091544-09; NCGC00091544-10; NCGC00091544-11; NCGC00091544-12; NCGC00091544-13; NCGC00091544-14; NCGC00091544-15; NCGC00091544-16; NCGC00091544-18; NCGC00091544-26; NCGC00091544-27; NCGC00179321-01; NCGC00179321-02; NCGC00254177-01; NCGC00259606-01; NCGC00261188-01; (1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol; AC-22346; AS-13729; CPD000059126; FR108523; SY017569; Estra-1,3,5(10)-triene-3,17b-diol; Oestra-1,3,5(10)-triene-3,17b-diol; US9034854, E2; US9040509, E2; US9422324, E2; US9561238, E2; WLN: L E5 B666TTT&J E1 FQ OQ; 17 beta-Estradiol, 1mg/ml in Acetonitrile; DB-246618; Estra-1(10),2,4-triene-3,17beta-diol; Estra-1,5(10)-triene-3,17.beta.-diol; Estradiol, meets USP testing specifications; 3,17beta-dihydroxyestra-1,3,5(10)-trien; CS-0694760; E7376; Estra-1,3,5(10)-triene-3,17beta-diol-; EU-0100503; KG70300000; NS00008517; NS00115904; Oestra-1,5(10)-triene-3,17.beta.-diol; 3,17beta-Dihydroxy-1,3,5(10)-estratriene; Estradiol Solution in Acetonitrile, 100ug/mL; C00951; D00105; EN300-119518; Estradiol Solution in Acetonitrile, 1000ug/mL; (17b)-Estra-1,3,5(10)-triene-3,17-diol; 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol; 17-beta-Estradiol 100 |Ig/mL in Acetonitrile; 17.beta.-Estra-1,5(10)-triene-3,17-diol; 17.beta.-Oestra-1,5(10)-triene-3,17-diol; ETHINYLESTRADIOL IMPURITY D [EP IMPURITY]; 17-beta-Estradiol 100 microg/mL in Acetonitrile; F358087; Q422416; SR-01000721892; (17|_)-Estra-1,3,5(10)-triene-3,17-diol; (17|A)-Estra-1,3,5(10)-triene-3,17-diol; 13beta-Methyl-1,3,5(10)-gonatriene-3,17beta-ol; Estra-1,5(10)-triene-3,17-diol (17.beta.)-; ESTRADIOL BENZOATE IMPURITY A [EP IMPURITY]; ESTRADIOL VALERATE IMPURITY A [EP IMPURITY]; SR-01000075866-1; SR-01000075866-4; SR-01000721892-3; BRD-K18910433-001-04-4; BRD-K18910433-001-36-6; BRD-K18910433-001-43-2; estra-1(10),2,4-triene-3,17-diol, (17beta)-; Estra-1,5(10)-triene-3,17-diol, (17.beta.)-; Z1521553843; B8B5AEF5-4957-49EB-A14F-444A8212C482; beta-Estradiol, BioReagent, powder, suitable for cell culture; Estradiol, United States Pharmacopeia (USP) Reference Standard; 13.BETA.-METHYL-1,3,5(10)-GONATRIENE-3,17.BETA.-OL; beta-Estradiol, powder, gamma-irradiated, suitable for cell culture; Estra-1,3,5(10)-triene-3,17-diol, (6,7-(sup 3)H,17-beta)-; (9beta,13alpha,14beta,17alpha)-estra-1,3,5(10)-triene-3,17-diol; Estradiol, Pharmaceutical Secondary Standard; Certified Reference Material; Beta-estradiol; 17beta-Estradiol; 17b-Oestradiol; 3,17b-Dihydroxyestra-1,3,5(10)-triene; (13S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-beta-diol; |A-Estradiol; 1,3,5-?Estratriene-?3,17|A-diol; 17|A-Estradiol; 3,17|A-Dihydroxy-1,3,5(10)-estratriene; Dihydrofolliculin; Estradiol; Estriol EP Impurity D; Ethinylestradiol EP Impurity D; Estradiol Valerate EP Impurity A; Estradiol (viên màu trắng)Sinónimos